Une candidature complète en une minute — un CV et une lettre de motivation personnalisés, prêts à être envoyés.
Sci-Rec Belgium is seeking an accomplished Chief Executive Officer to lead its European Life Sciences business. The role requires strategic oversight of regulated laboratory services across pharmaceutical, biotech and healthcare markets, and a track record in driving organic and acquisitive growth within multi-site operations.
Reporting to the parent organisation, the CEO will define divisional strategy, accelerate profitability and guide M&A integration while maintaining scientific integrity
Chief Executive Officer – Life Sciences
The Opportunity
A rapidly growing international Life Sciences testing, research and technical services organisation is seeking an accomplished Chief Executive Officer to lead the continued development of its European Life Sciences business. The organisation brings together specialist businesses serving highly regulated pharmaceutical, biotechnology, medical device, diagnostics and healthcare markets. Operating through a decentralised structure, the group combines the technical expertise, customer relationships and entrepreneurial culture of its individual businesses with the investment capability and strategic support of a larger international organisation. The Life Sciences business provides specialist services throughout the product development and commercial lifecycle, encompassing areas such as pharmaceutical testing, analytical laboratory services, medical device testing, clinical and scientific services, validation, quality assurance and regulatory support. This appointment represents a significant opportunity to lead an established and growing portfolio while shaping its next phase of organic and acquisitive development.
The Role
The CEO will assume overall responsibility for the strategic, commercial and operational performance of the Life Sciences business. Working closely with the Managing Directors and senior leadership teams of the individual operating companies, the successful candidate will define the divisional strategy, accelerate profitable growth and identify opportunities for greater collaboration across the portfolio. The role carries significant P&L responsibility and requires an executive capable of operating across both highly technical regulated environments and commercially driven service businesses. Alongside organic development, the CEO will play an important role in the continued expansion of the organisation through M&A, integration and the development of complementary capabilities and geographic markets.
Key Responsibilities
Candidate Profile
We are seeking an accomplished senior executive with substantial leadership experience within the Life Sciences testing, laboratory, CRO, medical device, pharmaceutical services or wider scientific services market. The successful candidate is likely to have operated at CEO, Managing Director, Divisional President, Segment Head, Business Unit Director, Regional Director or equivalent executive level.
Candidates should demonstrate:
Relevant Market Experience
Particularly relevant backgrounds may include leadership within organisations providing:
Candidates do not necessarily need experience across every discipline. More important is a strong understanding of regulated, technically complex and people-led Life Sciences service businesses.
Leadership Style
The organisation is seeking an executive who combines commercial ambition, scientific credibility and entrepreneurial leadership. This is not a traditional highly centralised corporate environment.
The successful candidate will need to provide clear strategic direction and establish accountability while allowing specialist businesses and their management teams to retain the agility, customer proximity and technical expertise that have contributed to their success. They must therefore be capable of moving comfortably between board-level strategy, financial performance, M&A, customer development and detailed conversations with scientific and operational leadership teams. A collaborative approach will be essential. The objective is not simply to consolidate businesses, but to create an environment in which specialist organisations can grow faster together than they could independently.